IDEXX Laboratories/ US45168D1046 /
| 2024-04-19 9:59:53 PM | Chg. -1.50 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 476.29USD | -0.31% | 28,588 Turnover: 13.56 mill. |
-Bid Size: - | -Ask Size: - | 39.58 bill.USD | - | 46.84 |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 533.8450 | 555.1670 | 587.6670 | 649.4740 | 702.1770 | ||||||
| Intangible Assets | 58.4680 | 52.5430 | 99.0350 | 97.6720 | 84.5000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 1,152.8360 | 1,231.8230 | 1,481.5480 | 1,645.2880 | 1,764.6710 | ||||||
| Inventories | 195.0190 | 209.8730 | 269.0300 | 367.8230 | 380.2820 | ||||||
| Accounts Receivable | 269.3120 | 331.4290 | 368.3480 | 400.6190 | 457.4450 | ||||||
| Cash and Cash Equivalents | 90.3260 | 383.9280 | 144.4540 | 112.5460 | 453.9320 | ||||||
| Current Assets | 679.6390 | 1,062.7380 | 955.6550 | 1,101.4770 | 1,495.2540 | ||||||
| Total Assets | 1,832.4750 | 2,294.5610 | 2,437.2030 | 2,746.7650 | 3,259.9250 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 72.1720 | 74.5580 | 116.1400 | 110.2210 | 110.6430 | ||||||
| Long-term debt | 698.9100 | 858.4920 | 775.2050 | 694.3870 | 622.8830 | ||||||
| Liabilities to Banks | 288.8000 | 0.0000 | 0.0000 | - | - | ||||||
| Provisions | 322.9000 | 415.6000 | 458.9000 | - | - | ||||||
| Liabilities | 1,654.6500 | 1,661.7660 | 1,747.2110 | 2,138.0280 | 1,775.3950 | ||||||
| Share Capital | 10.5710 | 10.6460 | 10.6880 | 10.7190 | 10.7510 | ||||||
| Total Equity | 177.8250 | 632.7950 | 689.9920 | 608.7370 | 1,484.5300 | ||||||
| Minority Interests | .3520 | .7070 | 0.0000 | 0.0000 | - | ||||||
| Total liabilities equity | 1,832.4750 | 2,294.5610 | 2,437.2030 | 2,746.7650 | 3,259.9250 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 2,406.9080 | 2,706.6550 | 3,215.3600 | 3,367.3240 | 3,660.9530 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 552.8460 | 694.5240 | 932.0280 | 898.7650 | 1,097.1280 | ||||||
| Interest Income | -30.6280 | -32.5390 | -29.3740 | -38.7930 | -35.9520 | ||||||
| Income Before Taxes | 522.2180 | 661.9850 | 902.6540 | 859.9720 | 1,061.1760 | ||||||
| Income Taxes | 94.4260 | 79.8540 | 157.8100 | 180.8830 | 216.1340 | ||||||
| Minority Interests Profit | .0720 | .3550 | -.0010 | 0.0000 | - | ||||||
| Net Income | 427.7200 | 581.7760 | 744.8450 | 679.0890 | 845.0420 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 459.1580 | 648.0630 | 755.5460 | 542.9840 | 906.5100 | ||||||
| Cash Flow from Investing Activities | -205.5280 | -109.3760 | -292.9670 | -195.3500 | -125.2540 | ||||||
| Cash Flow from Financing | -286.4090 | -248.4160 | -697.4140 | -370.9360 | -441.9960 | ||||||
| Decrease / Increase in Cash | -33.4680 | 293.6020 | -239.4740 | -31.9080 | 341.3860 | ||||||
| Employees | 9,200 | 9,300 | 10,350 | - | - | ||||||
